866-997-4948(US-Canada Toll Free)

Published on : Sep 01, 2017

Recently during an experiment, researchers have managed to revitalize nerve cells that were damaged by a condition like Parkinson's disease, in monkeys. The Japanese group are assured and claim that their attempts could prompt stem cell trials in human patients before the finish of 2018. Parkinson's disease is responsible for the continuous loss of nerve cells that discharge dopamine. This dopamine is a chemical that enables the control over body development. In the experiment, the scientists figured out a similar kind of loss of cells in macaque monkeys as well. They were treated by replacing their cell by human stem cell. After two years of having precursor dopamine neurons, extracted from human stem cells, the creatures indicated huge change in their side effects.

Researchers Claims Artificial Stems Cells to Be Equally Effective as Human Stem Cells

Induced pluripotent stem cells (iPS) - are made by hereditarily reinventing standard grown-up cells, with the goal that they return to an embryonic-like state. In this state, they would then be able to be persuaded to form into various grown-up cells, such as dopamine neurons. Prof Jun Takahashi, a Scientist from Kyoto University, stated that according to the work published in journal Nature, the artificially developed cells were also equally effective as the ones developed in the brain of macaques. He also added that since the iPS cells are not that difficult to extract, best iPS cells can be filtered to be used for the remedial treatment. Moreover, as per the research, the success of the experiment is dependent on the donor cells, and not on the number of recivers they were used for.